- Home
- HOTH vs GENK Comparison
HOTH vs GENK Comparison
Compare HOTH & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- GENK
- Stock Information
- Founded
- HOTH 2017
- GENK 2011
- Country
- HOTH United States
- GENK United States
- Employees
- HOTH N/A
- GENK N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- HOTH Health Care
- GENK Consumer Discretionary
- Exchange
- HOTH Nasdaq
- GENK Nasdaq
- Market Cap
- HOTH 18.0M
- GENK 16.3M
- IPO Year
- HOTH 2019
- GENK 2023
- Fundamental
- Price
- HOTH $1.16
- GENK $2.49
- Analyst Decision
- HOTH Strong Buy
- GENK Strong Buy
- Analyst Count
- HOTH 2
- GENK 2
- Target Price
- HOTH $4.50
- GENK $7.00
- AVG Volume (30 Days)
- HOTH 316.4K
- GENK 60.5K
- Earning Date
- HOTH 11-12-2025
- GENK 11-07-2025
- Dividend Yield
- HOTH N/A
- GENK 1.20%
- EPS Growth
- HOTH N/A
- GENK N/A
- EPS
- HOTH N/A
- GENK N/A
- Revenue
- HOTH N/A
- GENK $217,449,000.00
- Revenue This Year
- HOTH N/A
- GENK $12.35
- Revenue Next Year
- HOTH N/A
- GENK $14.62
- P/E Ratio
- HOTH N/A
- GENK N/A
- Revenue Growth
- HOTH N/A
- GENK 9.36
- 52 Week Low
- HOTH $0.66
- GENK $2.31
- 52 Week High
- HOTH $3.80
- GENK $9.04
- Technical
- Relative Strength Index (RSI)
- HOTH 38.64
- GENK 39.21
- Support Level
- HOTH $1.14
- GENK $2.31
- Resistance Level
- HOTH $1.22
- GENK $2.85
- Average True Range (ATR)
- HOTH 0.08
- GENK 0.19
- MACD
- HOTH -0.01
- GENK -0.02
- Stochastic Oscillator
- HOTH 38.57
- GENK 30.99
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.